96 related articles for article (PubMed ID: 7372460)
1. Carcinogen testing & public information.
Upton AC
Hastings Cent Rep; 1980 Feb; 10(1):9-10. PubMed ID: 7372460
[No Abstract] [Full Text] [Related]
2. Technical background information report on carcinogenesis bioassay of 1,2-dibromoethane (EDB).
Clin Toxicol; 1979 Apr; 14(4):473-8. PubMed ID: 380885
[No Abstract] [Full Text] [Related]
3. Carcinogenesis studies design and experimental data interpretation/evaluation at the National Toxicology Program.
Huff JE; Moore JA
Prog Clin Biol Res; 1984; 141():43-64. PubMed ID: 6718388
[No Abstract] [Full Text] [Related]
4. Quantitative risk assessment: report of the Subcommittee on Environmental Carcinogenesis, National Cancer Advisory Board.
Samuels SW; Adamson RH
J Natl Cancer Inst; 1985 Apr; 74(4):945-51. PubMed ID: 3857389
[No Abstract] [Full Text] [Related]
5. Identification of chemicals for testing in the rodent cancer bioassay.
Takihi N; Rosenkranz HS; Klopman G
Qual Assur; 1993 Sep; 2(3):232-43. PubMed ID: 8137083
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of reduced protocols for carcinogenicity testing of chemicals: report of a joint EPA/NIEHS workshop.
Lai DY; Baetcke KP; Vu VT; Cotruvo JA; Eustis SL
Regul Toxicol Pharmacol; 1994 Apr; 19(2):183-201. PubMed ID: 8041916
[TBL] [Abstract][Full Text] [Related]
7. Of mice and men: what animal tests of carcinogens mean to us.
Devita VT; Kennedy HP
Conn Med; 1980 Sep; 44(9):581-3. PubMed ID: 7408482
[No Abstract] [Full Text] [Related]
8. Neurologists strike gold in drug screen effort.
Abbott A
Nature; 2002 May; 417(6885):109. PubMed ID: 12000928
[No Abstract] [Full Text] [Related]
9. Federal policy. Stem-cell funds decision may have minimal impact on HIV/AIDS researchers.
Zack JA
AIDS Policy Law; 2001 Aug; 16(15):1, 4. PubMed ID: 11548387
[No Abstract] [Full Text] [Related]
10. Human genome agreements.
Holtzman NA
Science; 1997 Jan; 275(5300):602. PubMed ID: 9019812
[No Abstract] [Full Text] [Related]
11. Can public policy curtail obesity?
Rorick C
MLO Med Lab Obs; 2005 Mar; 37(3):48, 47. PubMed ID: 15828366
[No Abstract] [Full Text] [Related]
12. The new RAC: restructuring of the National Institutes of Health recombinant DNA Advisory Committee.
Beach JE
Food Drug Law J; 1999; 54(1):49-53. PubMed ID: 11758560
[No Abstract] [Full Text] [Related]
13. The development of new cancer drugs: a joint venture in public policy by the National Cancer Institute and Food and Drug Administration.
Crout JR
Cancer Treat Rep; 1982 Sep; 66(9):1705-7. PubMed ID: 6811133
[No Abstract] [Full Text] [Related]
14. The National Institutes of Health Anticonvulsant Drug Development Program: screening for efficacy.
White HS; Wolf HH; Woodhead JH; Kupferberg HJ
Adv Neurol; 1998; 76():29-39. PubMed ID: 9408461
[TBL] [Abstract][Full Text] [Related]
15. Need for public debate about fertility treatments.
Naviaux RK; Singh KK
Nature; 2001 Sep; 413(6854):347. PubMed ID: 11574848
[No Abstract] [Full Text] [Related]
16. U.S. regulatory policy. Courts ruled no forum for data-quality fights.
Kaiser J
Science; 2006 Mar; 311(5767):1536. PubMed ID: 16543423
[No Abstract] [Full Text] [Related]
17. Breakthrough of the year. Breakdowns of 2001.
Science; 2001 Dec; 294(5551):2446. PubMed ID: 11752541
[No Abstract] [Full Text] [Related]
18. Xenotransplant risks to be aired at forum.
Kaiser J
Science; 1997 Feb; 275(5301):743. PubMed ID: 11644894
[No Abstract] [Full Text] [Related]
19. Racing to share pathology data.
Berman JJ
Am J Clin Pathol; 2004 Feb; 121(2):169-71. PubMed ID: 14983928
[No Abstract] [Full Text] [Related]
20. Direct black 38, direct blue 6, direct brown 95, benzidine derived dyes.
Thomas AW; Boeniger MF; Weber MG; Stein HP; Upton AC; Millar JD
Am Ind Hyg Assoc J; 1978 Aug; 39(8):A-18-A-24. PubMed ID: 581253
[No Abstract] [Full Text] [Related]
[Next] [New Search]
